• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码RNA:长链非编码RNA、piRNA和小核仁RNA作为阿尔茨海默病可靠的血浆生物标志物

Non-Coding RNAs: lncRNA, piRNA, and snoRNA as Robust Plasma Biomarkers of Alzheimer's Disease.

作者信息

Xin Ruomin, Kim Elizabeth, Li Wei Tse, Wang-Rodriguez Jessica, Ongkeko Weg M

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of California, La Jolla, San Diego, CA 92093, USA.

Research Service, VA San Diego Healthcare System, San Diego, CA 92161, USA.

出版信息

Biomolecules. 2025 Jun 3;15(6):806. doi: 10.3390/biom15060806.

DOI:10.3390/biom15060806
PMID:40563446
Abstract

Alzheimer's disease (AD) is a leading cause of dementia worldwide. As current diagnostic approaches remain limited in sensitivity and accessibility, there is a critical need for novel, non-invasive biomarkers aiding early detection. Non-coding RNAs (ncRNAs), including long non-coding RNAs (lncRNAs), PIWI-interacting RNAs (piRNAs), and small nucleolar RNAs (snoRNAs), have emerged as promising candidates due to their regulatory roles in gene expression and association with diseases. In this study, we systematically profiled ncRNA expression from RNA sequencing data of 48 AD and 22 control blood tissue samples, aiming to evaluate their utility as biomarkers for AD classification. Differential expression analysis revealed widespread dysregulation of lncRNAs and piRNAs, with over 5000 lncRNAs and nearly 1000 piRNAs significantly upregulated in AD. Weighted gene co-expression network analysis (WGCNA) identified multiple ncRNA modules associated with the AD phenotype. Using supervised machine learning approaches, we evaluated the diagnostic potential of ncRNA expression profiles, including single-gene, multi-gene, and module-level models. Random Forest models trained on individual genes identified 121 ncRNAs with AUROC > 0.8. Feature importance analysis emphasized ncRNAs such as lnc-MYEF2-3, lnc-PRKACB2, and HBII-115 as major contributors to diagnostic accuracy. These findings support the potential of ncRNA signatures as reliable and non-invasive biomarkers for AD diagnosis.

摘要

阿尔茨海默病(AD)是全球痴呆症的主要病因。由于目前的诊断方法在敏感性和可及性方面仍然有限,因此迫切需要新的非侵入性生物标志物来辅助早期检测。非编码RNA(ncRNA),包括长链非编码RNA(lncRNA)、PIWI相互作用RNA(piRNA)和小核仁RNA(snoRNA),因其在基因表达中的调控作用以及与疾病的关联,已成为有前景的候选生物标志物。在本研究中,我们从48例AD和22例对照血液组织样本的RNA测序数据中系统地分析了ncRNA表达,旨在评估它们作为AD分类生物标志物的效用。差异表达分析显示lncRNA和piRNA广泛失调,超过5000种lncRNA和近1000种piRNA在AD中显著上调。加权基因共表达网络分析(WGCNA)确定了多个与AD表型相关的ncRNA模块。使用监督机器学习方法,我们评估了ncRNA表达谱的诊断潜力,包括单基因、多基因和模块水平模型。基于单个基因训练的随机森林模型识别出121种AUROC>0.8的ncRNA。特征重要性分析强调lnc-MYEF2-3、lnc-PRKACB2和HBII-115等ncRNA是诊断准确性的主要贡献者。这些发现支持了ncRNA特征作为AD诊断可靠且非侵入性生物标志物的潜力。

相似文献

1
Non-Coding RNAs: lncRNA, piRNA, and snoRNA as Robust Plasma Biomarkers of Alzheimer's Disease.非编码RNA:长链非编码RNA、piRNA和小核仁RNA作为阿尔茨海默病可靠的血浆生物标志物
Biomolecules. 2025 Jun 3;15(6):806. doi: 10.3390/biom15060806.
2
Non-coding RNA biomarkers in Alzheimer's disease.阿尔茨海默病中的非编码RNA生物标志物
Clin Chim Acta. 2025 Aug 15;576:120427. doi: 10.1016/j.cca.2025.120427. Epub 2025 Jun 14.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Blood biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症无创诊断的血液生物标志物。
Cochrane Database Syst Rev. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179.
5
Decoding the role of novel long noncoding RNAs lnc-SLC6A12-1:3 and lnc-SLC6A12-7:5 in regulating the expression of GAD1 and SLC6A12 in cholangiocarcinoma.解码新型长链非编码RNA lnc-SLC6A12-1:3和lnc-SLC6A12-7:5在调节胆管癌中GAD1和SLC6A12表达方面的作用。
Comput Biol Chem. 2025 Jun 20;119:108562. doi: 10.1016/j.compbiolchem.2025.108562.
6
Speech changes in old age: Methodological considerations for speech-based discrimination of healthy ageing and Alzheimer's disease.老年言语变化:基于言语的健康衰老与阿尔茨海默病鉴别方法学的考虑。
Int J Lang Commun Disord. 2024 Jan-Feb;59(1):13-37. doi: 10.1111/1460-6984.12888. Epub 2023 May 4.
7
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
8
Integrative single-cell RNA sequencing and mendelian randomization analysis reveal the potential role of synaptic vesicle cycling-related genes in Alzheimer's disease.整合单细胞RNA测序和孟德尔随机化分析揭示突触小泡循环相关基因在阿尔茨海默病中的潜在作用。
J Prev Alzheimers Dis. 2025 May;12(5):100097. doi: 10.1016/j.tjpad.2025.100097. Epub 2025 Feb 28.
9
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
10
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用:系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.

本文引用的文献

1
Identification of RN7SK LncRNA as a novel biomarker in Alzheimer's disease using bioinformatics and expression analysis.利用生物信息学和表达分析鉴定RN7SK长链非编码RNA作为阿尔茨海默病的新型生物标志物
Sci Rep. 2024 Dec 28;14(1):31192. doi: 10.1038/s41598-024-82490-9.
2
SnoRNAs: Exploring Their Implication in Human Diseases.snRNA:探索其在人类疾病中的意义。
Int J Mol Sci. 2024 Jun 29;25(13):7202. doi: 10.3390/ijms25137202.
3
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests.
阿尔茨海默病的高精度血液检测在准确性上可与临床脑脊液检测相媲美或优于后者。
Nat Med. 2024 Apr;30(4):1085-1095. doi: 10.1038/s41591-024-02869-z. Epub 2024 Feb 21.
4
Maturation of small nucleolar RNAs: from production to function.小核仁RNA的成熟:从产生到发挥功能
RNA Biol. 2023 Jan;20(1):715-736. doi: 10.1080/15476286.2023.2254540. Epub 2023 Oct 5.
5
Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.循环长非编码 RNA 作为阿尔茨海默病 (AD) 的新型诊断生物标志物:系统评价和荟萃分析。
PLoS One. 2023 Mar 22;18(3):e0281784. doi: 10.1371/journal.pone.0281784. eCollection 2023.
6
Long non-coding RNAs: definitions, functions, challenges and recommendations.长非编码 RNA:定义、功能、挑战与建议。
Nat Rev Mol Cell Biol. 2023 Jun;24(6):430-447. doi: 10.1038/s41580-022-00566-8. Epub 2023 Jan 3.
7
Alzheimer's Disease: Treatment Strategies and Their Limitations.阿尔茨海默病:治疗策略及其局限性。
Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954.
8
MEF2C ameliorates learning, memory, and molecular pathological changes in Alzheimer’s disease in vivo and in vitro.MEF2C 可改善阿尔茨海默病的体内和体外学习、记忆和分子病理变化。
Acta Biochim Biophys Sin (Shanghai). 2022 Jan 25;54(1):77-90. doi: 10.3724/abbs.2021012.
9
Diagnosis and Treatment of Alzheimer's Disease:: An Update.阿尔茨海默病的诊断与治疗:最新进展
Dela J Public Health. 2021 Sep 27;7(4):74-85. doi: 10.32481/djph.2021.09.009. eCollection 2021 Sep.
10
Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's disease.血浆细胞外囊泡中的小核仁 RNA 及其作为阿尔茨海默病诊断生物标志物的鉴别能力。
Neurobiol Dis. 2021 Nov;159:105481. doi: 10.1016/j.nbd.2021.105481. Epub 2021 Aug 17.